Adversitement
Supreme Court Restrains Patanjali from Advertising Medicinal Products Amid Allegations of Misrepresentation
Published On : 2024-02-28T16:21:47+0530 [ IST ] |
Author : Mayur_Tembhare
Home
Supreme Court of India, New Delhi, | Image Courtesy : Adobe Stock
India :
The Supreme Court, on Tuesday, restrained Patanjali Ayurved, a company co-founded by yoga guru Ramdev and dealing in herbal products, from advertising or branding products meant for treating diseases until further orders. The court issued notices to Patanjali Ayurved and its managing director Acharya Balkrishna, questioning their compliance with the court's directives regarding advertising and the medicinal efficacy of their products.
A bench comprising Justices Hima Kohli and Ahsanuddin Amanullah expressed concern over alleged misrepresentation in Patanjali's advertisements, stating that the entire country had been "taken for a ride." The court referred to the firm's assurance in November last year to refrain from violating laws and making false claims about its products.
The bench observed that Patanjali's advertisements appeared to flout the court's order, indicating a violation of their undertaking. Consequently, the court issued notices for contempt proceedings against Patanjali and its managing director.
The Additional Solicitor General (ASG) representing the Centre was questioned about the government's actions regarding the alleged misrepresentation by Patanjali. The ASG mentioned the need for consultations with relevant authorities before taking action, prompting the court to emphasize the urgency of addressing the issue.
During the proceedings, the court also criticized Patanjali's advertisements and cautioned against conditional bans when the company failed to adhere to its assurances. Patanjali's counsel informed the court about the establishment of a research laboratory, but the bench stressed the importance of respecting regulations and systems while conducting research.
The matter was adjourned to March 19, allowing Patanjali to respond to the notices. The court underscored the need for prompt action to address alleged violations and maintain transparency in advertising medicinal products.
Source : Supreme Court of India
Tags : Supreme Court , Medicinal Products , Contempt Proceedings , Court Directive. , Ramdev , Advertising , Misrepresentation , Patanjali Ayurved ,
Summary : The Supreme Court restrained Patanjali Ayurved from advertising medicinal products amid allegations of misrepresentation until further orders. The court issued notices to the company and its managing director for potential contempt proceedings, citing concerns over non-compliance with directives. Patanjali's advertisements were criticized for allegedly flouting the court's order, prompting the court to stress the urgency of addressing the issue. The matter was adjourned to March 19 for Patanjali to respond, emphasizing the importance of transparency in advertising medicinal products.
Adversitement